B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test Two-Pronged attack on tough blood cancer
Disease control OngoingThis study is testing the safety and effectiveness of combining two drugs, venetoclax and inotuzumab ozogamicin, for adults with B-cell acute lymphoblastic leukemia (B-ALL) that has come back or hasn't responded to previous chemotherapy. The main goal is to find the highest safe …
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for kids with Tough-to-Treat leukemia: experimental immune therapy trial
Disease control OngoingThis study is testing an experimental immune therapy called tisagenlecleucel (a type of CAR-T cell therapy) in children and young adults (ages 1-25) with high-risk B-cell acute lymphoblastic leukemia (B-ALL). The treatment is for patients who still show small amounts of cancer ce…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Second shot at hope: early booster CAR-T therapy aims to lock out leukemia in kids
Disease control OngoingThis study is testing if giving a second dose of a personalized immune cell therapy (tisagenlecleucel) early can help keep leukemia from coming back in children and young adults. It focuses on patients whose cancer returned or didn't respond to other treatments and who are alread…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC